Litcius/Paper detail

Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic

Shengxian Li, Jianhua Liu, Mengyao Sun, Jixue Wang, Handong Wang, Yinghao Sun

2020Frontiers in Pharmacology51 citationsDOIOpen Access PDF

Abstract

Cell membrane (CM)-camouflaged nanocarriers (CMNPs) are the tools of a biomimetic strategy that has attracted significant attention. With a wide range of nanoparticle cores and CMs available, various creative CMNP designs have been studied for cancer diagnosis and therapy. The various functional CM molecules available allow CMNPs to demonstrate excellent properties such as prolonged circulation time, immune escape ability, reduced systemic toxicity, and homologous targeting ability when camouflaged with CMs derived from various types of natural cells including red and white blood cells, platelets, stem cells, and cancer cells. In this review, we summarize various CMNPs employed for cancer chemotherapy, immunotherapy, phototherapy, and in vivo imaging. We also predict future challenges and opportunities for fundamental and clinical studies.

Topics & Concepts

NanocarriersCancer cellCancerMedicineCancer immunotherapyCancer therapyIn vivoImmune systemImmunotherapyCancer researchNanotechnologyImmunologyPharmacologyBiologyMaterials scienceInternal medicineBiotechnologyDrugNanoplatforms for cancer theranosticsExtracellular vesicles in diseaseNanoparticle-Based Drug Delivery
Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic | Litcius